Terms: = Cervical cancer AND MYC, c-Myc, 4609, ENSG00000136997
446 results:
1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
2. Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
Cao C; Xu Q; Zhu Z; Xu M; Wei Y; Lin S; Cheng S; Zhi W; Hong P; Huang X; Lin D; Cao G; Meng Y; Wu P; Peng T; Wei J; Ding W; Huang X; Sung W; Chen G; Ma D; Li G; Wu P
Cancer Lett; 2024 Apr; 588():216809. PubMed ID: 38471646
[TBL] [Abstract] [Full Text] [Related]
3. HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt/β-catenin signaling.
Xu Z; Guo Y; Wang L; Cui J
Exp Cell Res; 2024 Feb; 435(2):113949. PubMed ID: 38266865
[TBL] [Abstract] [Full Text] [Related]
4. Expression of miR-152 in cervical cancer and its influence on cisplatin resistance.
Wu J; Chi X; Yang Q; Li J
Afr Health Sci; 2023 Jun; 23(2):246-255. PubMed ID: 38223603
[TBL] [Abstract] [Full Text] [Related]
5. Upregulation of FAM83F by c-myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
[TBL] [Abstract] [Full Text] [Related]
6. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer.
Cheng Z; Wang H; Yang Z; Li J; Chen X
BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
[TBL] [Abstract] [Full Text] [Related]
7. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract] [Full Text] [Related]
8. Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-myc, and FOXM1 in human cervical carcinoma Hela cells.
Gharbaran R; Sayibou Z; Atamturktur S; Ofosu-Mensah JJ; Soto J; Boodhan N; Kolya S; Onwumere O; Chang L; Somenarain L; Redenti S
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23527. PubMed ID: 37681557
[TBL] [Abstract] [Full Text] [Related]
9. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
[TBL] [Abstract] [Full Text] [Related]
10. HDACs alters negatively to the tumor immune microenvironment in gynecologic cancers.
Yan M; Cao H; Tao K; Xiao B; Chu Y; Ma D; Huang X; Han Y; Ji T
Gene; 2023 Nov; 885():147704. PubMed ID: 37572797
[TBL] [Abstract] [Full Text] [Related]
11. PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
Wei X; Sun K; Li S; Lin C; Wei Z
Tissue Cell; 2023 Aug; 83():102151. PubMed ID: 37467687
[TBL] [Abstract] [Full Text] [Related]
12. ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in cervical cancer.
Li QS; Zheng PS
Cancer Res; 2023 Sep; 83(18):3095-3114. PubMed ID: 37350664
[TBL] [Abstract] [Full Text] [Related]
13. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract] [Full Text] [Related]
14. WIF1 was downregulated in cervical cancer due to promoter methylation.
Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X
Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343
[TBL] [Abstract] [Full Text] [Related]
15. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and myc.
Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X
Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026
[TBL] [Abstract] [Full Text] [Related]
16. The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.
Aghbash PS; Hemmat N; Baradaran B; Mokhtarzadeh A; Poortahmasebi V; Oskuee MA; Baghi HB
Oncol Res; 2022; 30(3):99-116. PubMed ID: 37305016
[TBL] [Abstract] [Full Text] [Related]
17. Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins.
Yapindi L; Bowley T; Kurtaneck N; Bergeson RL; James K; Wilbourne J; Harrod CK; Hernandez BY; Emerling BM; Yates C; Harrod R
Virology; 2023 Aug; 585():1-20. PubMed ID: 37257253
[TBL] [Abstract] [Full Text] [Related]
18. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
19. HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.
Nie G; Tang B; Lv M; Li D; Li T; Ou R; Xu Y; Wen J
Cell Biol Int; 2023 Aug; 47(8):1327-1343. PubMed ID: 37191290
[TBL] [Abstract] [Full Text] [Related]
20. miR-145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on myc.
Hu C; Liu T; Zhang W; Sun Y; Jiang D; Zhang X; Liu Y; Mao S; Xu Y; Pan J; Wang J; Huang Y; Yang S; Yang K
FASEB J; 2023 Apr; 37(4):e22839. PubMed ID: 36946075
[TBL] [Abstract] [Full Text] [Related]
[Next]